Nippon Shokubai（4114）株式概要日本触媒株式会社は、日本および海外で化学製品の製造・販売を行っている。 詳細4114 ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長1/6過去の実績2/6財務の健全性6/6配当金3/6報酬当社が推定した公正価値より51.7%で取引されている 収益は年間4.89%増加すると予測されています リスク分析5.38%の配当は、利益やフリーキャッシュフローによって十分にカバーされていない すべてのリスクチェックを見る4114 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥2.10k6.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-11b492b2016201920222025202620282031Revenue JP¥492.3bEarnings JP¥20.6bAdvancedSet Fair ValueView all narrativesNippon Shokubai Co., Ltd. 競合他社TokuyamaSymbol: TSE:4043Market cap: JP¥362.3bNippon KayakuSymbol: TSE:4272Market cap: JP¥277.8bFujimiSymbol: TSE:5384Market cap: JP¥337.9bAica Kogyo CompanySymbol: TSE:4206Market cap: JP¥233.6b価格と性能株価の高値、安値、推移の概要Nippon Shokubai過去の株価現在の株価JP¥2,102.0052週高値JP¥2,548.0052週安値JP¥1,633.00ベータ0.331ヶ月の変化1.84%3ヶ月変化-7.40%1年変化27.86%3年間の変化53.35%5年間の変化57.45%IPOからの変化34.53%最新ニュースReported Earnings • Jun 23Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • May 15The Nippon Shokubai Co., Ltd. (TSE:4114) Annual Results Are Out And Analysts Have Published New ForecastsNippon Shokubai Co., Ltd. ( TSE:4114 ) shareholders are probably feeling a little disappointed, since its shares fell...お知らせ • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026.Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 22 June 2026. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 4.4%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).最新情報をもっと見るRecent updatesReported Earnings • Jun 23Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • May 15The Nippon Shokubai Co., Ltd. (TSE:4114) Annual Results Are Out And Analysts Have Published New ForecastsNippon Shokubai Co., Ltd. ( TSE:4114 ) shareholders are probably feeling a little disappointed, since its shares fell...お知らせ • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026.Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 22 June 2026. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 4.4%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).Price Target Changed • Mar 02Price target increased by 11% to JP¥2,080Up from JP¥1,870, the current price target is an average from 3 analysts. New target price is 18% below last closing price of JP¥2,524. Stock is up 38% over the past year. The company is forecast to post earnings per share of JP¥111 for next year compared to JP¥114 last year.お知らせ • Feb 28Nippon Shokubai Co., Ltd. to Report Fiscal Year 2026 Results on May 13, 2026Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2026 results at 1:00 PM, Tokyo Standard Time on May 13, 2026分析記事 • Feb 07Results: Nippon Shokubai Co., Ltd. Beat Earnings Expectations And Analysts Now Have New ForecastsIt's been a good week for Nippon Shokubai Co., Ltd. ( TSE:4114 ) shareholders, because the company has just released...Reported Earnings • Feb 07Third quarter 2026 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2026 results: EPS: JP¥45.65 (up from JP¥33.63 in 3Q 2025). Revenue: JP¥99.1b (down 2.6% from 3Q 2025). Net income: JP¥6.76b (up 33% from 3Q 2025). Profit margin: 6.8% (up from 5.0% in 3Q 2025). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) exceeded analyst estimates by 94%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.分析記事 • Jan 15The Return Trends At Nippon Shokubai (TSE:4114) Look PromisingWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...分析記事 • Dec 28Does Nippon Shokubai (TSE:4114) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Dec 07Nippon Shokubai (TSE:4114) Has Announced A Dividend Of ¥50.00The board of Nippon Shokubai Co., Ltd. ( TSE:4114 ) has announced that it will pay a dividend on the 22nd of June, with...Declared Dividend • Dec 06First half dividend of JP¥50.00 announcedShareholders will receive a dividend of JP¥50.00. Ex-date: 30th March 2026 Payment date: 22nd June 2026 Dividend yield will be 5.4%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not covered by earnings (103% earnings payout ratio) nor is it covered by cash flows (261% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 15% to bring the payout ratio under control. EPS is expected to grow by 29% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Nov 18Nippon Shokubai Co., Ltd. to Report Q3, 2026 Results on Feb 05, 2026Nippon Shokubai Co., Ltd. announced that they will report Q3, 2026 results at 1:00 PM, Tokyo Standard Time on Feb 05, 2026Reported Earnings • Nov 08Second quarter 2026 earnings: EPS misses analyst expectationsSecond quarter 2026 results: EPS: JP¥21.13 (down from JP¥28.05 in 2Q 2025). Revenue: JP¥99.0b (down 2.8% from 2Q 2025). Net income: JP¥3.18b (down 26% from 2Q 2025). Profit margin: 3.2% (down from 4.2% in 2Q 2025). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.分析記事 • Sep 22Nippon Shokubai (TSE:4114) Has Announced That Its Dividend Will Be Reduced To ¥50.00Nippon Shokubai Co., Ltd. ( TSE:4114 ) is reducing its dividend from last year's comparable payment to ¥50.00 on the...分析記事 • Sep 08Nippon Shokubai (TSE:4114) Has Announced That Its Dividend Will Be Reduced To ¥50.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...分析記事 • Aug 25Nippon Shokubai (TSE:4114) Has Announced That Its Dividend Will Be Reduced To ¥50.00Nippon Shokubai Co., Ltd. ( TSE:4114 ) has announced that on 5th of December, it will be paying a dividend of¥50.00...お知らせ • Aug 14Nippon Shokubai Co., Ltd. to Report Q2, 2026 Results on Nov 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q2, 2026 results on Nov 07, 2025分析記事 • Aug 11Nippon Shokubai (TSE:4114) Will Pay A Smaller Dividend Than Last YearNippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...Reported Earnings • Aug 08First quarter 2026 earnings: EPS exceeds analyst expectationsFirst quarter 2026 results: EPS: JP¥29.26 (down from JP¥29.98 in 1Q 2025). Revenue: JP¥101.2b (down 3.7% from 1Q 2025). Net income: JP¥4.43b (down 4.3% from 1Q 2025). Profit margin: 4.4% (in line with 1Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 28%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.お知らせ • Jul 31Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 5,000,000 shares, representing 3.3% for ¥7,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 5,000,000 shares, representing 3.3% of its issued share capital (excluding treasury stock), for a total purchase price of ¥7,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 27, 2026. As of June 30, 2025, the company has 151,691,868 issued shares (excluding treasury stock) and 4,308,132 treasury shares.分析記事 • Jul 27Nippon Shokubai (TSE:4114) Is Reducing Its Dividend To ¥50.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...分析記事 • Jul 13Nippon Shokubai's (TSE:4114) Dividend Is Being Reduced To ¥50.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...Declared Dividend • Jul 09Final dividend of JP¥50.00 announcedShareholders will receive a dividend of JP¥50.00. Ex-date: 29th September 2025 Payment date: 5th December 2025 Dividend yield will be 6.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not covered by earnings (100% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 11% to bring the payout ratio under control. EPS is expected to grow by 28% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Jun 26Nippon Shokubai's U.S. Group Company Acquires Iscc Plus Certification for Acrylic Acid and Superabsorbent PolymersNippon Shokubai Group companies in the United States have acquired ISCC PLUS certification for acrylic acid (hereinafter "AA") and superabsorbent polymers (hereinafter "SAP") produced locally. This enables Nippon Shokubai group to globally supply AA and SAP with a carbon footprint considered net zero. Through promoting the use of ISCC PLUS-certified AA and SAP, NipponShokubai Group aims to contribute to reducing environmental impact across the supply chain and to advancing a circular economy. Toward carbon neutrality by 2050, Nippon ShokubAI Group will continue to implement the "transformation" outlined in its long-term vision and mid-term management plan to enhance customer value. Nippon Shokubia Group commits and declares its compliance with the ISCC PLUS requirements in accordance with the latest ISCC regulations. ISCC (International Sustainability and Carbon Certification): It is a third-party certification program developed by International Sustainability and Carbon Certification (ISCC) system GmbH based in Germany to manage and guarantee sustainable raw materials and products such as biomass and recycled materials in the supply chain. Carbon footprint considered net zero: ISCC PLUS-certified products incorporate the biogenic CO2 removal associated with biomass growth into their carbon footprint calculations. The carbon footprints of these products are considered effectively net zero through the proportionally offset based on the share of biomass-derived feedstock allocated using the mass balance method. The mass balance method: When biomass-derived and petroleum-derived raw materials are used together in production, the proportion of biomass input can be allocated to specific end products. This method is officially recognized under the ISCC PLUS certification system.お知らせ • Jun 24Nippon Shokubai Plans to Expand Its Gmp-Compliant Nucleic Acid Drug API Manufacturing Capacity TenfoldNippon Shokubai CO., LTD. has announced a plan to expand its GMP (1)-compliant manufacturing capacity for nucleic acid drug "active pharmaceutical ingredients" (APIs) tenfold in response to rapidly growing global demand in the nucleic acid drug market. Nucleic acid drugs are generally defined as "chemically synthesized drugs with oligonucleotides as active ingredients that exert their effects without being translated into proteins." As a new modality following small molecule and antibody drugs, they are expected to be applied in areas such as rare diseases, neurological disorders, and cancers -- fields where conventional treatments have been limited. The capacity expansion will involve the installation of a large-scale production line with ten times the capacity (several kilograms per batch) of the company's existing line. The new facility is scheduled to begin operation in 2027, making it one of Japan's largest CDMOs, capable of manufacturing nucleic acid drug APIs for common diseases that require large-scale supply. The company will strengthen its manufacturing system to meet a wide range of needs, from non-clinical stages to large-scale commercial production. Leveraging Nippon Shokubai's long-standing expertise in organic synthesis and rigorous quality control systems, the company manufactures oligonucleotides and peptides, which are medium-sized molecule APIs. Its GMP-compliant facilities, among the most advanced in Japan, have been audited and visited by multiple pharmaceutical companies, all of which have given high evaluations, establishing Nippon ShokubAI's strong reputation in the industry. The company will continue to provide flexible contract manufacturing services that meet diverse needs and contribute to a sustainable society by ensuring a stable supply of medium-sized molecule APIs that support human health and life.Reported Earnings • Jun 20Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: JP¥114 (up from JP¥70.48 in FY 2024). Revenue: JP¥409.3b (up 4.4% from FY 2024). Net income: JP¥17.4b (up 58% from FY 2024). Profit margin: 4.2% (up from 2.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Price Target Changed • Jun 17Price target increased by 7.8% to JP¥1,800Up from JP¥1,670, the current price target is an average from 4 analysts. New target price is 9.9% above last closing price of JP¥1,639. Stock is up 5.3% over the past year. The company is forecast to post earnings per share of JP¥95.85 for next year compared to JP¥114 last year.お知らせ • May 31Nippon Shokubai Co., Ltd. to Report Q1, 2026 Results on Aug 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025Major Estimate Revision • May 29Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from JP¥425.4b to JP¥415.5b. EPS estimate also fell from JP¥115 per share to JP¥101 per share. Net income forecast to shrink 8.3% next year vs 7.5% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥1,715 to JP¥1,670. Share price was steady at JP¥1,653 over the past week.Reported Earnings • May 15Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: JP¥114 (up from JP¥70.48 in FY 2024). Revenue: JP¥409.3b (up 4.4% from FY 2024). Net income: JP¥17.4b (up 58% from FY 2024). Profit margin: 4.2% (up from 2.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • May 13+ 3 more updatesNippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025.Buy Or Sell Opportunity • May 07Now 20% overvaluedOver the last 90 days, the stock has fallen 9.8% to JP¥1,681. The fair value is estimated to be JP¥1,397, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%. For the next 3 years, revenue is forecast to grow by 2.8% per annum. Earnings are also forecast to grow by 8.4% per annum over the same time period.Buy Or Sell Opportunity • Apr 18Now 20% overvaluedOver the last 90 days, the stock has fallen 9.8% to JP¥1,686. The fair value is estimated to be JP¥1,399, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%. For the next 3 years, revenue is forecast to grow by 2.9% per annum. Earnings are also forecast to grow by 8.3% per annum over the same time period.分析記事 • Apr 15Returns At Nippon Shokubai (TSE:4114) Appear To Be Weighed DownFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...お知らせ • Apr 02Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation.Nippon Shokubai Co., Ltd. (TSE:4114) agreed to acquire Emulsion Technology Co.,Ltd. from JSR Corporation for ¥7.2 billion on November 12, 2024. As part of consideration, ¥7.2 billion is paid towards common equity of Emulsion Technology Co.,Ltd. For the period ending March 31, 2024, Emulsion Technology Co.,Ltd. reported total revenue of ¥13.3 billion, EBIT of ¥918 million and net income of ¥647 million. The expected completion of the transaction is April 1, 2025. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation on April 1, 2025.Upcoming Dividend • Mar 21Upcoming dividend of JP¥54.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 23 June 2025. Payout ratio and cash payout ratio are on the higher end at 77% and 85% respectively. Trailing yield: 5.8%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).分析記事 • Feb 11Nippon Shokubai (TSE:4114) Has Announced A Dividend Of ¥54.00Nippon Shokubai Co., Ltd. ( TSE:4114 ) will pay a dividend of ¥54.00 on the 23rd of June. This means the annual payment...分析記事 • Feb 10Nippon Shokubai Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextAs you might know, Nippon Shokubai Co., Ltd. ( TSE:4114 ) recently reported its quarterly numbers. It looks like a...Reported Earnings • Feb 07Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: JP¥33.63 (up from JP¥18.90 in 3Q 2024). Revenue: JP¥101.7b (up 3.8% from 3Q 2024). Net income: JP¥5.10b (up 73% from 3Q 2024). Profit margin: 5.0% (up from 3.0% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.6%. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • Feb 06Nippon Shokubai Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 13, 2025分析記事 • Jan 14Nippon Shokubai Co., Ltd.'s (TSE:4114) P/E Is On The MarkNippon Shokubai Co., Ltd.'s ( TSE:4114 ) price-to-earnings (or "P/E") ratio of 21.8x might make it look like a strong...お知らせ • Dec 12Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd.Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd. on December 9, 2024. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Lilac Pharma Co., Ltd. on December 9, 2024.Declared Dividend • Dec 06First half dividend of JP¥54.00 announcedShareholders will receive a dividend of JP¥54.00. Ex-date: 28th March 2025 Payment date: 23rd June 2025 Dividend yield will be 5.9%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not adequately covered by earnings (90.4% earnings payout ratio). However, it is covered by cash flows (67% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share is expected to grow by 39% over the next 3 years, which should maintain adequate earnings cover for the dividend.New Risk • Nov 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (90% payout ratio). Shareholders have been diluted in the past year (2.8% increase in shares outstanding).分析記事 • Nov 29Is Nippon Shokubai (TSE:4114) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Buy Or Sell Opportunity • Nov 14Now 20% undervaluedOver the last 90 days, the stock has risen 16% to JP¥1,855. The fair value is estimated to be JP¥2,321, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has declined by 6.7%. For the next 3 years, revenue is forecast to grow by 3.1% per annum. Earnings are also forecast to grow by 9.5% per annum over the same time period.お知らせ • Nov 11Nippon Shokubai Co., Ltd. to Report Q3, 2025 Results on Feb 06, 2025Nippon Shokubai Co., Ltd. announced that they will report Q3, 2025 results at 3:00 PM, Tokyo Standard Time on Feb 06, 2025Reported Earnings • Nov 09Second quarter 2025 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2025 results: EPS: JP¥28.05 (up from JP¥14.54 in 2Q 2024). Revenue: JP¥101.8b (up 5.0% from 2Q 2024). Net income: JP¥4.29b (up 88% from 2Q 2024). Profit margin: 4.2% (up from 2.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 5.3%. Earnings per share (EPS) also surpassed analyst estimates by 66%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Upcoming Dividend • Sep 20Upcoming dividend of JP¥35.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).分析記事 • Sep 10Nippon Shokubai Co., Ltd. (TSE:4114) Not Lagging Market On Growth Or PricingWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 13x, you may consider Nippon...お知らせ • Aug 15Nippon Shokubai Co., Ltd. to Report Q2, 2025 Results on Nov 07, 2024Nippon Shokubai Co., Ltd. announced that they will report Q2, 2025 results on Nov 07, 2024分析記事 • Aug 06An Intrinsic Calculation For Nippon Shokubai Co., Ltd. (TSE:4114) Suggests It's 20% UndervaluedKey Insights Using the 2 Stage Free Cash Flow to Equity, Nippon Shokubai fair value estimate is JP¥1,781 Nippon...Buy Or Sell Opportunity • Aug 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.7% to JP¥1,418. The fair value is estimated to be JP¥1,788, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 3.2% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Declared Dividend • Jul 11Final dividend of JP¥35.00 announcedShareholders will receive a dividend of JP¥35.00. Ex-date: 27th September 2024 Payment date: 5th December 2024 Dividend yield will be 7.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by both earnings (81% earnings payout ratio) and cash flows (29% cash payout ratio). The dividend has increased by an average of 9.8% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to decline by 52% over the next 3 years. Since a fall of 10% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.分析記事 • Jun 27There May Be Reason For Hope In Nippon Shokubai's (TSE:4114) Disappointing EarningsShareholders appeared unconcerned with Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) lackluster earnings report last week...Reported Earnings • Jun 25Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: JP¥282. Revenue: JP¥392.0b (down 6.6% from FY 2023). Net income: JP¥11.0b (down 43% from FY 2023). Profit margin: 2.8% (down from 4.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan.Price Target Changed • Jun 13Price target increased by 7.3% to JP¥1,501Up from JP¥1,399, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of JP¥1,524. Stock is up 11% over the past year. The company is forecast to post earnings per share of JP¥75.90 for next year compared to JP¥70.48 last year.分析記事 • May 31The Price Is Right For Nippon Shokubai Co., Ltd. (TSE:4114)With a price-to-earnings (or "P/E") ratio of 23.2x Nippon Shokubai Co., Ltd. ( TSE:4114 ) may be sending very bearish...Reported Earnings • May 16Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: JP¥282. Revenue: JP¥392.0b (down 6.6% from FY 2023). Net income: JP¥11.0b (down 43% from FY 2023). Profit margin: 2.8% (down from 4.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan.お知らせ • May 15Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024.お知らせ • May 14Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 4,000,000 shares, representing 2.59% for ¥5,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.59% of its issued share capital (excluding treasury stock), for a total purchase price of ¥5,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 28, 2025. As of March 31, 2024, the company has 154,642,750 issued shares (excluding treasury stock) and 1,357,240 treasury shares.分析記事 • Apr 11Here's Why Nippon Shokubai (TSE:4114) Can Manage Its Debt ResponsiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Upcoming Dividend • Mar 21Upcoming dividend of JP¥90.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Payout ratio is on the higher end at 81%, however this is supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).分析記事 • Mar 03Nippon Shokubai (TSE:4114) Has Affirmed Its Dividend Of ¥90.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) investors are due to receive a payment of ¥90.00 per share on 24th of June...お知らせ • Mar 02Nippon Shokubai Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024お知らせ • Feb 09+ 1 more updateNippon Shokubai Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2023Nippon Shokubai Co., Ltd. announced that For the fiscal year ending March 31, 2023, the company to forecasts to pay a dividend of JPY 90.00 per share as compared to JPY 90.00 per share paid a year ago.Reported Earnings • Feb 08Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2024 results: EPS: JP¥75.71 (down from JP¥160 in 3Q 2023). Revenue: JP¥98.1b (down 7.4% from 3Q 2023). Net income: JP¥2.95b (down 54% from 3Q 2023). Profit margin: 3.0% (down from 6.0% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 51%. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Major Estimate Revision • Dec 07Consensus EPS estimates fall by 13%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥342 to JP¥296 per share. Revenue forecast steady at JP¥389.8b. Net income forecast to grow 4.7% next year vs 12% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥6,050 to JP¥5,375. Share price was steady at JP¥5,256 over the past week.Price Target Changed • Dec 06Price target decreased by 17% to JP¥5,375Down from JP¥6,483, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of JP¥5,313. Stock is down 2.0% over the past year. The company is forecast to post earnings per share of JP¥296 for next year compared to JP¥488 last year.お知らせ • Nov 30Nippon Shokubai Co., Ltd. to Report Q3, 2024 Results on Feb 06, 2024Nippon Shokubai Co., Ltd. announced that they will report Q3, 2024 results on Feb 06, 2024お知らせ • Nov 08Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 700,000 shares, representing 1.78% for ¥4,500 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 700,000 shares, representing 1.78% of its issued share capital (excluding treasury stock), for a total purchase price of ¥4,500 million. The shares will be repurchased at a price of ¥5,654 per share. The purpose of the program is to improve capital efficiency and implement agile capital policies in response to changes in the business environment. As of September 30, 2023, the company has 39,361,462 issued shares (excluding treasury stock) and 1,438,538 treasury shares.Reported Earnings • Nov 08Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: JP¥58.14 (down from JP¥162 in 2Q 2023). Revenue: JP¥96.9b (down 10% from 2Q 2023). Net income: JP¥2.29b (down 65% from 2Q 2023). Profit margin: 2.4% (down from 6.0% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 7.3%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Price Target Changed • Oct 05Price target decreased by 8.3% to JP¥5,783Down from JP¥6,307, the current price target is an average from 4 analysts. New target price is 10% above last closing price of JP¥5,251. Stock is down 5.0% over the past year. The company is forecast to post earnings per share of JP¥368 for next year compared to JP¥488 last year.Upcoming Dividend • Sep 21Upcoming dividend of JP¥90.00 per share at 3.2% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.5%).お知らせ • Sep 06Nippon Shokubai Co., Ltd. to Report Q2, 2024 Results on Nov 07, 2023Nippon Shokubai Co., Ltd. announced that they will report Q2, 2024 results on Nov 07, 2023New Risk • Aug 09New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 4.0% Last year net profit margin: 6.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.0% net profit margin).Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: JP¥116 (vs JP¥190 in 1Q 2023)First quarter 2024 results: EPS: JP¥116 (down from JP¥190 in 1Q 2023). Revenue: JP¥97.4b (down 13% from 1Q 2023). Net income: JP¥4.58b (down 40% from 1Q 2023). Profit margin: 4.7% (down from 6.8% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Jul 21Consensus EPS estimates fall by 20%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥423.2b to JP¥407.8b. EPS estimate also fell from JP¥456 per share to JP¥365 per share. Net income forecast to shrink 26% next year vs 2.8% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥7,193 to JP¥6,307. Share price was steady at JP¥5,269 over the past week.Reported Earnings • Jun 25Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: JP¥488 (down from JP¥595 in FY 2022). Revenue: JP¥419.6b (up 14% from FY 2022). Net income: JP¥19.4b (down 18% from FY 2022). Profit margin: 4.6% (down from 6.4% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Major Estimate Revision • Jun 22Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥436.5b to JP¥416.2b. EPS estimate also fell from JP¥534 per share to JP¥383 per share. Net income forecast to shrink 22% next year vs 3.4% growth forecast for Chemicals industry in Japan . Consensus price target broadly unchanged at JP¥7,193. Share price was steady at JP¥5,396 over the past week.お知らせ • Jun 02Nippon Shokubai Co., Ltd. to Report Q1, 2024 Results on Aug 07, 2023Nippon Shokubai Co., Ltd. announced that they will report Q1, 2024 results on Aug 07, 2023Reported Earnings • May 17Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: JP¥488 (down from JP¥595 in FY 2022). Revenue: JP¥419.6b (up 14% from FY 2022). Net income: JP¥19.4b (down 18% from FY 2022). Profit margin: 4.6% (down from 6.4% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.お知らせ • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023.お知らせ • May 12Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥90.00 per share at 3.5% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 22 June 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).Reported Earnings • Feb 07Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: JP¥160 (down from JP¥175 in 3Q 2022). Revenue: JP¥105.9b (up 9.3% from 3Q 2022). Net income: JP¥6.37b (down 8.8% from 3Q 2022). Profit margin: 6.0% (down from 7.2% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.1%. Earnings per share (EPS) exceeded analyst estimates by 33%. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Feb 06+ 1 more updateNippon Shokubai Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023Nippon Shokubai Co., Ltd. expected to pay dividend of JPY 90 per share for the fiscal year ending March 31, 2023 compared to JPY 100 per share paid a year ago.お知らせ • Dec 16Nippon Shokubai Co., Ltd. to Report Q3, 2023 Results on Feb 06, 2023Nippon Shokubai Co., Ltd. announced that they will report Q3, 2023 results on Feb 06, 2023Reported Earnings • Nov 16Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: EPS: JP¥162 (down from JP¥168 in 2Q 2022). Revenue: JP¥108.2b (up 24% from 2Q 2022). Net income: JP¥6.48b (down 3.4% from 2Q 2022). Profit margin: 6.0% (down from 7.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) exceeded analyst estimates by 27%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.株主還元4114JP ChemicalsJP 市場7D0.2%-2.2%-2.2%1Y27.9%48.1%39.6%株主還元を見る業界別リターン: 4114過去 1 年間で48.1 % の収益を上げたJP Chemicals業界を下回りました。リターン対市場: 4114は、過去 1 年間で39.6 % のリターンを上げたJP市場を下回りました。価格変動Is 4114's price volatile compared to industry and market?4114 volatility4114 Average Weekly Movement3.1%Chemicals Industry Average Movement5.3%Market Average Movement4.4%10% most volatile stocks in JP Market9.3%10% least volatile stocks in JP Market2.2%安定した株価: 4114 、 JP市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 4114の 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19414,880Kazuhiro Nodawww.shokubai.co.jp/ja/日本触媒株式会社は、日本および海外で化学製品の製造・販売に従事している。事業セグメントは2つ：素材事業」と「ソリューション事業」の2つのセグメントから構成されている。素材事業」は、アクリル酸、アクリル酸エステル、高吸水性樹脂、エチレンオキサイド、エチレングリコール、エタノールアミン、無水マレイン酸、プロセス触媒、MMAモノマー・ポリマー等の製造・販売を行っている。ソリューション事業では、コンクリート混和剤用ポリマー、グリコールエーテル、第2級アルコールエトキシレート、水溶性ポリマー、医薬中間体、電子情報材料、ヨウ素化合物、粘接着剤・塗料用樹脂、エチレンイミン誘導体、粘着加工品、自動車用触媒、脱硝触媒、ダイオキシン類分解触媒、排ガス処理装置、湿式空気酸化触媒、電池用材料などを製造・販売している。また、アクリル酸エステル、マレイミド、環状アミド、開始剤、水性・溶剤性・可溶性ポリマー、無機・有機複合微粒子、液化ガス・燃料電池材料なども提供している。また、合成ゴムラテックスやアクリルエマルジョンをベースとした産業資材、土木建築資材、アクリルエマルジョンやファイン製品の製造・販売も行っている。旧社名は日本触媒化学工業(株)で、1991年に日本触媒(株)に社名変更した。日本触媒は1941年に設立され、本社は大阪にある。もっと見るNippon Shokubai Co., Ltd. 基礎のまとめNippon Shokubai の収益と売上を時価総額と比較するとどうか。4114 基礎統計学時価総額JP¥310.58b収益（TTM）JP¥16.76b売上高(TTM)JP¥399.90b18.5xPER（株価収益率0.8xP/Sレシオ4114 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計4114 損益計算書（TTM）収益JP¥399.90b売上原価JP¥325.09b売上総利益JP¥74.81bその他の費用JP¥58.04b収益JP¥16.76b直近の収益報告Mar 31, 2026次回決算日Aug 07, 2026一株当たり利益（EPS）113.46グロス・マージン18.71%純利益率4.19%有利子負債／自己資本比率14.4%4114 の長期的なパフォーマンスは？過去の実績と比較を見る配当金5.4%現在の配当利回り101%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/29 16:37終値2026/06/29 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nippon Shokubai Co., Ltd. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関null nullAstris Advisory Japan, K.K.Mikiya YamadaBarclaysTakashi EnomotoBofA Global Research9 その他のアナリストを表示
Reported Earnings • Jun 23Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • May 15The Nippon Shokubai Co., Ltd. (TSE:4114) Annual Results Are Out And Analysts Have Published New ForecastsNippon Shokubai Co., Ltd. ( TSE:4114 ) shareholders are probably feeling a little disappointed, since its shares fell...
お知らせ • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026.
Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 22 June 2026. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 4.4%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
Reported Earnings • Jun 23Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • May 15The Nippon Shokubai Co., Ltd. (TSE:4114) Annual Results Are Out And Analysts Have Published New ForecastsNippon Shokubai Co., Ltd. ( TSE:4114 ) shareholders are probably feeling a little disappointed, since its shares fell...
お知らせ • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026.
Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥112 (down from JP¥114 in FY 2025). Revenue: JP¥399.9b (down 2.3% from FY 2025). Net income: JP¥16.8b (down 3.6% from FY 2025). Profit margin: 4.2% (in line with FY 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 22 June 2026. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 4.4%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
Price Target Changed • Mar 02Price target increased by 11% to JP¥2,080Up from JP¥1,870, the current price target is an average from 3 analysts. New target price is 18% below last closing price of JP¥2,524. Stock is up 38% over the past year. The company is forecast to post earnings per share of JP¥111 for next year compared to JP¥114 last year.
お知らせ • Feb 28Nippon Shokubai Co., Ltd. to Report Fiscal Year 2026 Results on May 13, 2026Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2026 results at 1:00 PM, Tokyo Standard Time on May 13, 2026
分析記事 • Feb 07Results: Nippon Shokubai Co., Ltd. Beat Earnings Expectations And Analysts Now Have New ForecastsIt's been a good week for Nippon Shokubai Co., Ltd. ( TSE:4114 ) shareholders, because the company has just released...
Reported Earnings • Feb 07Third quarter 2026 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2026 results: EPS: JP¥45.65 (up from JP¥33.63 in 3Q 2025). Revenue: JP¥99.1b (down 2.6% from 3Q 2025). Net income: JP¥6.76b (up 33% from 3Q 2025). Profit margin: 6.8% (up from 5.0% in 3Q 2025). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) exceeded analyst estimates by 94%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
分析記事 • Jan 15The Return Trends At Nippon Shokubai (TSE:4114) Look PromisingWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
分析記事 • Dec 28Does Nippon Shokubai (TSE:4114) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Dec 07Nippon Shokubai (TSE:4114) Has Announced A Dividend Of ¥50.00The board of Nippon Shokubai Co., Ltd. ( TSE:4114 ) has announced that it will pay a dividend on the 22nd of June, with...
Declared Dividend • Dec 06First half dividend of JP¥50.00 announcedShareholders will receive a dividend of JP¥50.00. Ex-date: 30th March 2026 Payment date: 22nd June 2026 Dividend yield will be 5.4%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not covered by earnings (103% earnings payout ratio) nor is it covered by cash flows (261% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 15% to bring the payout ratio under control. EPS is expected to grow by 29% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Nov 18Nippon Shokubai Co., Ltd. to Report Q3, 2026 Results on Feb 05, 2026Nippon Shokubai Co., Ltd. announced that they will report Q3, 2026 results at 1:00 PM, Tokyo Standard Time on Feb 05, 2026
Reported Earnings • Nov 08Second quarter 2026 earnings: EPS misses analyst expectationsSecond quarter 2026 results: EPS: JP¥21.13 (down from JP¥28.05 in 2Q 2025). Revenue: JP¥99.0b (down 2.8% from 2Q 2025). Net income: JP¥3.18b (down 26% from 2Q 2025). Profit margin: 3.2% (down from 4.2% in 2Q 2025). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
分析記事 • Sep 22Nippon Shokubai (TSE:4114) Has Announced That Its Dividend Will Be Reduced To ¥50.00Nippon Shokubai Co., Ltd. ( TSE:4114 ) is reducing its dividend from last year's comparable payment to ¥50.00 on the...
分析記事 • Sep 08Nippon Shokubai (TSE:4114) Has Announced That Its Dividend Will Be Reduced To ¥50.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...
分析記事 • Aug 25Nippon Shokubai (TSE:4114) Has Announced That Its Dividend Will Be Reduced To ¥50.00Nippon Shokubai Co., Ltd. ( TSE:4114 ) has announced that on 5th of December, it will be paying a dividend of¥50.00...
お知らせ • Aug 14Nippon Shokubai Co., Ltd. to Report Q2, 2026 Results on Nov 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q2, 2026 results on Nov 07, 2025
分析記事 • Aug 11Nippon Shokubai (TSE:4114) Will Pay A Smaller Dividend Than Last YearNippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...
Reported Earnings • Aug 08First quarter 2026 earnings: EPS exceeds analyst expectationsFirst quarter 2026 results: EPS: JP¥29.26 (down from JP¥29.98 in 1Q 2025). Revenue: JP¥101.2b (down 3.7% from 1Q 2025). Net income: JP¥4.43b (down 4.3% from 1Q 2025). Profit margin: 4.4% (in line with 1Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 28%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
お知らせ • Jul 31Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 5,000,000 shares, representing 3.3% for ¥7,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 5,000,000 shares, representing 3.3% of its issued share capital (excluding treasury stock), for a total purchase price of ¥7,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 27, 2026. As of June 30, 2025, the company has 151,691,868 issued shares (excluding treasury stock) and 4,308,132 treasury shares.
分析記事 • Jul 27Nippon Shokubai (TSE:4114) Is Reducing Its Dividend To ¥50.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...
分析記事 • Jul 13Nippon Shokubai's (TSE:4114) Dividend Is Being Reduced To ¥50.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) dividend is being reduced from last year's payment covering the same period to...
Declared Dividend • Jul 09Final dividend of JP¥50.00 announcedShareholders will receive a dividend of JP¥50.00. Ex-date: 29th September 2025 Payment date: 5th December 2025 Dividend yield will be 6.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not covered by earnings (100% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 11% to bring the payout ratio under control. EPS is expected to grow by 28% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Jun 26Nippon Shokubai's U.S. Group Company Acquires Iscc Plus Certification for Acrylic Acid and Superabsorbent PolymersNippon Shokubai Group companies in the United States have acquired ISCC PLUS certification for acrylic acid (hereinafter "AA") and superabsorbent polymers (hereinafter "SAP") produced locally. This enables Nippon Shokubai group to globally supply AA and SAP with a carbon footprint considered net zero. Through promoting the use of ISCC PLUS-certified AA and SAP, NipponShokubai Group aims to contribute to reducing environmental impact across the supply chain and to advancing a circular economy. Toward carbon neutrality by 2050, Nippon ShokubAI Group will continue to implement the "transformation" outlined in its long-term vision and mid-term management plan to enhance customer value. Nippon Shokubia Group commits and declares its compliance with the ISCC PLUS requirements in accordance with the latest ISCC regulations. ISCC (International Sustainability and Carbon Certification): It is a third-party certification program developed by International Sustainability and Carbon Certification (ISCC) system GmbH based in Germany to manage and guarantee sustainable raw materials and products such as biomass and recycled materials in the supply chain. Carbon footprint considered net zero: ISCC PLUS-certified products incorporate the biogenic CO2 removal associated with biomass growth into their carbon footprint calculations. The carbon footprints of these products are considered effectively net zero through the proportionally offset based on the share of biomass-derived feedstock allocated using the mass balance method. The mass balance method: When biomass-derived and petroleum-derived raw materials are used together in production, the proportion of biomass input can be allocated to specific end products. This method is officially recognized under the ISCC PLUS certification system.
お知らせ • Jun 24Nippon Shokubai Plans to Expand Its Gmp-Compliant Nucleic Acid Drug API Manufacturing Capacity TenfoldNippon Shokubai CO., LTD. has announced a plan to expand its GMP (1)-compliant manufacturing capacity for nucleic acid drug "active pharmaceutical ingredients" (APIs) tenfold in response to rapidly growing global demand in the nucleic acid drug market. Nucleic acid drugs are generally defined as "chemically synthesized drugs with oligonucleotides as active ingredients that exert their effects without being translated into proteins." As a new modality following small molecule and antibody drugs, they are expected to be applied in areas such as rare diseases, neurological disorders, and cancers -- fields where conventional treatments have been limited. The capacity expansion will involve the installation of a large-scale production line with ten times the capacity (several kilograms per batch) of the company's existing line. The new facility is scheduled to begin operation in 2027, making it one of Japan's largest CDMOs, capable of manufacturing nucleic acid drug APIs for common diseases that require large-scale supply. The company will strengthen its manufacturing system to meet a wide range of needs, from non-clinical stages to large-scale commercial production. Leveraging Nippon Shokubai's long-standing expertise in organic synthesis and rigorous quality control systems, the company manufactures oligonucleotides and peptides, which are medium-sized molecule APIs. Its GMP-compliant facilities, among the most advanced in Japan, have been audited and visited by multiple pharmaceutical companies, all of which have given high evaluations, establishing Nippon ShokubAI's strong reputation in the industry. The company will continue to provide flexible contract manufacturing services that meet diverse needs and contribute to a sustainable society by ensuring a stable supply of medium-sized molecule APIs that support human health and life.
Reported Earnings • Jun 20Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: JP¥114 (up from JP¥70.48 in FY 2024). Revenue: JP¥409.3b (up 4.4% from FY 2024). Net income: JP¥17.4b (up 58% from FY 2024). Profit margin: 4.2% (up from 2.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Price Target Changed • Jun 17Price target increased by 7.8% to JP¥1,800Up from JP¥1,670, the current price target is an average from 4 analysts. New target price is 9.9% above last closing price of JP¥1,639. Stock is up 5.3% over the past year. The company is forecast to post earnings per share of JP¥95.85 for next year compared to JP¥114 last year.
お知らせ • May 31Nippon Shokubai Co., Ltd. to Report Q1, 2026 Results on Aug 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025
Major Estimate Revision • May 29Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from JP¥425.4b to JP¥415.5b. EPS estimate also fell from JP¥115 per share to JP¥101 per share. Net income forecast to shrink 8.3% next year vs 7.5% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥1,715 to JP¥1,670. Share price was steady at JP¥1,653 over the past week.
Reported Earnings • May 15Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: JP¥114 (up from JP¥70.48 in FY 2024). Revenue: JP¥409.3b (up 4.4% from FY 2024). Net income: JP¥17.4b (up 58% from FY 2024). Profit margin: 4.2% (up from 2.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • May 13+ 3 more updatesNippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025.
Buy Or Sell Opportunity • May 07Now 20% overvaluedOver the last 90 days, the stock has fallen 9.8% to JP¥1,681. The fair value is estimated to be JP¥1,397, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%. For the next 3 years, revenue is forecast to grow by 2.8% per annum. Earnings are also forecast to grow by 8.4% per annum over the same time period.
Buy Or Sell Opportunity • Apr 18Now 20% overvaluedOver the last 90 days, the stock has fallen 9.8% to JP¥1,686. The fair value is estimated to be JP¥1,399, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 18%. For the next 3 years, revenue is forecast to grow by 2.9% per annum. Earnings are also forecast to grow by 8.3% per annum over the same time period.
分析記事 • Apr 15Returns At Nippon Shokubai (TSE:4114) Appear To Be Weighed DownFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
お知らせ • Apr 02Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation.Nippon Shokubai Co., Ltd. (TSE:4114) agreed to acquire Emulsion Technology Co.,Ltd. from JSR Corporation for ¥7.2 billion on November 12, 2024. As part of consideration, ¥7.2 billion is paid towards common equity of Emulsion Technology Co.,Ltd. For the period ending March 31, 2024, Emulsion Technology Co.,Ltd. reported total revenue of ¥13.3 billion, EBIT of ¥918 million and net income of ¥647 million. The expected completion of the transaction is April 1, 2025. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation on April 1, 2025.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥54.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 23 June 2025. Payout ratio and cash payout ratio are on the higher end at 77% and 85% respectively. Trailing yield: 5.8%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).
分析記事 • Feb 11Nippon Shokubai (TSE:4114) Has Announced A Dividend Of ¥54.00Nippon Shokubai Co., Ltd. ( TSE:4114 ) will pay a dividend of ¥54.00 on the 23rd of June. This means the annual payment...
分析記事 • Feb 10Nippon Shokubai Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextAs you might know, Nippon Shokubai Co., Ltd. ( TSE:4114 ) recently reported its quarterly numbers. It looks like a...
Reported Earnings • Feb 07Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: JP¥33.63 (up from JP¥18.90 in 3Q 2024). Revenue: JP¥101.7b (up 3.8% from 3Q 2024). Net income: JP¥5.10b (up 73% from 3Q 2024). Profit margin: 5.0% (up from 3.0% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.6%. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • Feb 06Nippon Shokubai Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 13, 2025
分析記事 • Jan 14Nippon Shokubai Co., Ltd.'s (TSE:4114) P/E Is On The MarkNippon Shokubai Co., Ltd.'s ( TSE:4114 ) price-to-earnings (or "P/E") ratio of 21.8x might make it look like a strong...
お知らせ • Dec 12Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd.Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd. on December 9, 2024. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Lilac Pharma Co., Ltd. on December 9, 2024.
Declared Dividend • Dec 06First half dividend of JP¥54.00 announcedShareholders will receive a dividend of JP¥54.00. Ex-date: 28th March 2025 Payment date: 23rd June 2025 Dividend yield will be 5.9%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not adequately covered by earnings (90.4% earnings payout ratio). However, it is covered by cash flows (67% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share is expected to grow by 39% over the next 3 years, which should maintain adequate earnings cover for the dividend.
New Risk • Nov 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (90% payout ratio). Shareholders have been diluted in the past year (2.8% increase in shares outstanding).
分析記事 • Nov 29Is Nippon Shokubai (TSE:4114) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Buy Or Sell Opportunity • Nov 14Now 20% undervaluedOver the last 90 days, the stock has risen 16% to JP¥1,855. The fair value is estimated to be JP¥2,321, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has declined by 6.7%. For the next 3 years, revenue is forecast to grow by 3.1% per annum. Earnings are also forecast to grow by 9.5% per annum over the same time period.
お知らせ • Nov 11Nippon Shokubai Co., Ltd. to Report Q3, 2025 Results on Feb 06, 2025Nippon Shokubai Co., Ltd. announced that they will report Q3, 2025 results at 3:00 PM, Tokyo Standard Time on Feb 06, 2025
Reported Earnings • Nov 09Second quarter 2025 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2025 results: EPS: JP¥28.05 (up from JP¥14.54 in 2Q 2024). Revenue: JP¥101.8b (up 5.0% from 2Q 2024). Net income: JP¥4.29b (up 88% from 2Q 2024). Profit margin: 4.2% (up from 2.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 5.3%. Earnings per share (EPS) also surpassed analyst estimates by 66%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Upcoming Dividend • Sep 20Upcoming dividend of JP¥35.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).
分析記事 • Sep 10Nippon Shokubai Co., Ltd. (TSE:4114) Not Lagging Market On Growth Or PricingWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 13x, you may consider Nippon...
お知らせ • Aug 15Nippon Shokubai Co., Ltd. to Report Q2, 2025 Results on Nov 07, 2024Nippon Shokubai Co., Ltd. announced that they will report Q2, 2025 results on Nov 07, 2024
分析記事 • Aug 06An Intrinsic Calculation For Nippon Shokubai Co., Ltd. (TSE:4114) Suggests It's 20% UndervaluedKey Insights Using the 2 Stage Free Cash Flow to Equity, Nippon Shokubai fair value estimate is JP¥1,781 Nippon...
Buy Or Sell Opportunity • Aug 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.7% to JP¥1,418. The fair value is estimated to be JP¥1,788, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 3.2% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Declared Dividend • Jul 11Final dividend of JP¥35.00 announcedShareholders will receive a dividend of JP¥35.00. Ex-date: 27th September 2024 Payment date: 5th December 2024 Dividend yield will be 7.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by both earnings (81% earnings payout ratio) and cash flows (29% cash payout ratio). The dividend has increased by an average of 9.8% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to decline by 52% over the next 3 years. Since a fall of 10% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.
分析記事 • Jun 27There May Be Reason For Hope In Nippon Shokubai's (TSE:4114) Disappointing EarningsShareholders appeared unconcerned with Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) lackluster earnings report last week...
Reported Earnings • Jun 25Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: JP¥282. Revenue: JP¥392.0b (down 6.6% from FY 2023). Net income: JP¥11.0b (down 43% from FY 2023). Profit margin: 2.8% (down from 4.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan.
Price Target Changed • Jun 13Price target increased by 7.3% to JP¥1,501Up from JP¥1,399, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of JP¥1,524. Stock is up 11% over the past year. The company is forecast to post earnings per share of JP¥75.90 for next year compared to JP¥70.48 last year.
分析記事 • May 31The Price Is Right For Nippon Shokubai Co., Ltd. (TSE:4114)With a price-to-earnings (or "P/E") ratio of 23.2x Nippon Shokubai Co., Ltd. ( TSE:4114 ) may be sending very bearish...
Reported Earnings • May 16Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: JP¥282. Revenue: JP¥392.0b (down 6.6% from FY 2023). Net income: JP¥11.0b (down 43% from FY 2023). Profit margin: 2.8% (down from 4.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan.
お知らせ • May 15Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024.
お知らせ • May 14Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 4,000,000 shares, representing 2.59% for ¥5,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.59% of its issued share capital (excluding treasury stock), for a total purchase price of ¥5,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 28, 2025. As of March 31, 2024, the company has 154,642,750 issued shares (excluding treasury stock) and 1,357,240 treasury shares.
分析記事 • Apr 11Here's Why Nippon Shokubai (TSE:4114) Can Manage Its Debt ResponsiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Upcoming Dividend • Mar 21Upcoming dividend of JP¥90.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Payout ratio is on the higher end at 81%, however this is supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).
分析記事 • Mar 03Nippon Shokubai (TSE:4114) Has Affirmed Its Dividend Of ¥90.00Nippon Shokubai Co., Ltd.'s ( TSE:4114 ) investors are due to receive a payment of ¥90.00 per share on 24th of June...
お知らせ • Mar 02Nippon Shokubai Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024
お知らせ • Feb 09+ 1 more updateNippon Shokubai Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2023Nippon Shokubai Co., Ltd. announced that For the fiscal year ending March 31, 2023, the company to forecasts to pay a dividend of JPY 90.00 per share as compared to JPY 90.00 per share paid a year ago.
Reported Earnings • Feb 08Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2024 results: EPS: JP¥75.71 (down from JP¥160 in 3Q 2023). Revenue: JP¥98.1b (down 7.4% from 3Q 2023). Net income: JP¥2.95b (down 54% from 3Q 2023). Profit margin: 3.0% (down from 6.0% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 51%. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Dec 07Consensus EPS estimates fall by 13%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥342 to JP¥296 per share. Revenue forecast steady at JP¥389.8b. Net income forecast to grow 4.7% next year vs 12% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥6,050 to JP¥5,375. Share price was steady at JP¥5,256 over the past week.
Price Target Changed • Dec 06Price target decreased by 17% to JP¥5,375Down from JP¥6,483, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of JP¥5,313. Stock is down 2.0% over the past year. The company is forecast to post earnings per share of JP¥296 for next year compared to JP¥488 last year.
お知らせ • Nov 30Nippon Shokubai Co., Ltd. to Report Q3, 2024 Results on Feb 06, 2024Nippon Shokubai Co., Ltd. announced that they will report Q3, 2024 results on Feb 06, 2024
お知らせ • Nov 08Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 700,000 shares, representing 1.78% for ¥4,500 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 700,000 shares, representing 1.78% of its issued share capital (excluding treasury stock), for a total purchase price of ¥4,500 million. The shares will be repurchased at a price of ¥5,654 per share. The purpose of the program is to improve capital efficiency and implement agile capital policies in response to changes in the business environment. As of September 30, 2023, the company has 39,361,462 issued shares (excluding treasury stock) and 1,438,538 treasury shares.
Reported Earnings • Nov 08Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: JP¥58.14 (down from JP¥162 in 2Q 2023). Revenue: JP¥96.9b (down 10% from 2Q 2023). Net income: JP¥2.29b (down 65% from 2Q 2023). Profit margin: 2.4% (down from 6.0% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 7.3%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Price Target Changed • Oct 05Price target decreased by 8.3% to JP¥5,783Down from JP¥6,307, the current price target is an average from 4 analysts. New target price is 10% above last closing price of JP¥5,251. Stock is down 5.0% over the past year. The company is forecast to post earnings per share of JP¥368 for next year compared to JP¥488 last year.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥90.00 per share at 3.2% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.5%).
お知らせ • Sep 06Nippon Shokubai Co., Ltd. to Report Q2, 2024 Results on Nov 07, 2023Nippon Shokubai Co., Ltd. announced that they will report Q2, 2024 results on Nov 07, 2023
New Risk • Aug 09New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 4.0% Last year net profit margin: 6.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.0% net profit margin).
Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: JP¥116 (vs JP¥190 in 1Q 2023)First quarter 2024 results: EPS: JP¥116 (down from JP¥190 in 1Q 2023). Revenue: JP¥97.4b (down 13% from 1Q 2023). Net income: JP¥4.58b (down 40% from 1Q 2023). Profit margin: 4.7% (down from 6.8% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Jul 21Consensus EPS estimates fall by 20%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥423.2b to JP¥407.8b. EPS estimate also fell from JP¥456 per share to JP¥365 per share. Net income forecast to shrink 26% next year vs 2.8% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥7,193 to JP¥6,307. Share price was steady at JP¥5,269 over the past week.
Reported Earnings • Jun 25Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: JP¥488 (down from JP¥595 in FY 2022). Revenue: JP¥419.6b (up 14% from FY 2022). Net income: JP¥19.4b (down 18% from FY 2022). Profit margin: 4.6% (down from 6.4% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Jun 22Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥436.5b to JP¥416.2b. EPS estimate also fell from JP¥534 per share to JP¥383 per share. Net income forecast to shrink 22% next year vs 3.4% growth forecast for Chemicals industry in Japan . Consensus price target broadly unchanged at JP¥7,193. Share price was steady at JP¥5,396 over the past week.
お知らせ • Jun 02Nippon Shokubai Co., Ltd. to Report Q1, 2024 Results on Aug 07, 2023Nippon Shokubai Co., Ltd. announced that they will report Q1, 2024 results on Aug 07, 2023
Reported Earnings • May 17Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: JP¥488 (down from JP¥595 in FY 2022). Revenue: JP¥419.6b (up 14% from FY 2022). Net income: JP¥19.4b (down 18% from FY 2022). Profit margin: 4.6% (down from 6.4% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
お知らせ • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023.
お知らせ • May 12Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 21, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥90.00 per share at 3.5% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 22 June 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).
Reported Earnings • Feb 07Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: JP¥160 (down from JP¥175 in 3Q 2022). Revenue: JP¥105.9b (up 9.3% from 3Q 2022). Net income: JP¥6.37b (down 8.8% from 3Q 2022). Profit margin: 6.0% (down from 7.2% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.1%. Earnings per share (EPS) exceeded analyst estimates by 33%. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Feb 06+ 1 more updateNippon Shokubai Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023Nippon Shokubai Co., Ltd. expected to pay dividend of JPY 90 per share for the fiscal year ending March 31, 2023 compared to JPY 100 per share paid a year ago.
お知らせ • Dec 16Nippon Shokubai Co., Ltd. to Report Q3, 2023 Results on Feb 06, 2023Nippon Shokubai Co., Ltd. announced that they will report Q3, 2023 results on Feb 06, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: EPS: JP¥162 (down from JP¥168 in 2Q 2022). Revenue: JP¥108.2b (up 24% from 2Q 2022). Net income: JP¥6.48b (down 3.4% from 2Q 2022). Profit margin: 6.0% (down from 7.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) exceeded analyst estimates by 27%. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
